Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Harvard Business School
Fuji
Julphar
Medtronic
Colorcon
Johnson and Johnson
UBS

Generated: April 22, 2018

DrugPatentWatch Database Preview

ANCOBON Drug Profile

« Back to Dashboard

Which patents cover Ancobon, and when can generic versions of Ancobon launch?

Ancobon is a drug marketed by Valeant and is included in one NDA.

The generic ingredient in ANCOBON is flucytosine. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the flucytosine profile page.
Drug patent expirations by year for ANCOBON
Pharmacology for ANCOBON
Medical Subject Heading (MeSH) Categories for ANCOBON
Synonyms for ANCOBON
117969-88-7
130256-61-0
16469-EP2281563A1
16469-EP2316459A1
1LD
2-Hydroxy-4-amino-5-fluoro-pyrimidine
2-Hydroxy-4-amino-5-fluoropyrimidine
2-Pyrimidinol, 4-amino-5-fluoro- (9CI)
2(1H)-Pyrimidinone, 4-amino-5-fluoro-
2(1H)-Pyrimidinone, 4-amino-5-fluoro-)
2(1H)-Pyrimidinone, 5-fluoro-3,4-dihydro-4-imino- (9CI)
2(1H)-Pyrimidinone, 6-amino-5-fluoro-
2022-85-7
22P857
4-Amino-1,2-dihydro-5-fluoro-2-oxopyrimidine
4-AMINO-2-HYDROXY-5-FLUOROPYRIMIDINE
4-Amino-5-fluoro-1H-pyrimidin-2-one
4-Amino-5-fluoro-2-hydroxypyrimidine
4-Amino-5-fluoro-2-hyroxypyrimidine
4-Amino-5-fluoro-2-pyrimidinol
4-AMINO-5-FLUORO-2(1H)-PYRIMIDINE
4-Amino-5-fluoro-2(1H)-pyrimidinone
4-amino-5-fluoro-2(1H)-pyrimidinone; Flucytosine
4-amino-5-fluoro-pyrimidin-2-ol
4-amino-5-fluoropyrimidin-2-ol
4-Amino-5-fluoropyrimidin-2(1H)-one
5 Fluoro Cytosine
5-FC
5-Flucytosine
5-fluoro cytosine
5-FLUORO-4-IMINO-1,2,3,4-TETRAHYDROPYRIMIDIN-2-ONE
5-fluoro-4-imino-1,3-dihydropyrimidin-2-one
5-Fluorocystosine
5-fluorocytocine
5-Fluorocytosin
5-Fluorocytosine
5-Fluorocytosine, 98% 250mg
5-Fluorocytosine, Antibiotic for Culture Media Use Only
5-Fluorocytosine, nucleoside analog
5-Fluorocytosine, Vetec(TM) reagent grade, 99%
5-Flurocytosine
5987P
6-Amino-2-oxo-5-fluoropyrimidine
6-amino-5-fluoro-1,2-dihydropyrimidin-2-one
6-amino-5-fluoro-1H-pyrimidin-2-one
6-amino-5-fluoro-3-hydropyrimidin-2-one
6-amino-5-fluoropyrimidin-2(1H)-one
9074P
AB0005647
AB00444223-16
AB00513969
AB00513969_03
AB00513969_04
AB00513969-02
AB0071040
AB1000113
AC-11748
AC1L1FRT
AC1Q52OQ
ACMC-209zxs
AJ-24237
AK-33991
AK340283
AKOS004912683
AKOS005063821
AKOS015896898
AKOS030241326
Alcobon
AM20090149
AMX10130
AN-9456
Ancobon (TN)
Ancotil
Ancotyl
ANW-50846
B-7734
BC203393
BCP0726000281
BCP9000692
BPBio1_000956
BR-33991
BSPBio_000868
C4H4FN3O
CAS-2022-85-7
CCG-100837
CCG-213434
CF-075
CHEBI:5100
CHEMBL1463
CPD000059047
CS-1935
CTK7B7906
CTK7E0508
CTK8A0854
Cytosine, 5-fluoro-
Cytosine, 5-fluoro- (6CI,7CI,8CI)
Cytosine, 5-fluoro-(6CI,7CI,8CI)
D00323
D0S5WG
D83282DT06
DB-005380
DB01099
DSSTox_CID_3059
DSSTox_GSID_23059
DSSTox_RID_76856
DTXSID3023059
EC 217-968-7
EINECS 217-968-7
F-3010
F0321
Flucitosina
Flucitosina [DCIT]
Flucystine
Flucytosin
flucytosina
flucytosine
Flucytosine (Ancobon)
Flucytosine (JP15/USP/INN)
Flucytosine (JP17/USP/INN)
Flucytosine [USAN:INN:BAN:JAN]
Flucytosine [USAN:USP:INN:BAN:JAN]
Flucytosine [USAN)
Flucytosine 2.0 mg/ml in Methanol
Flucytosine for system suitability, European Pharmacopoeia (EP) Reference Standard
Flucytosine, 5-Fluorocytosine
Flucytosine, European Pharmacopoeia (EP) Reference Standard
Flucytosine, pharmaceutical secondary standard; traceable to USP, PhEur
Flucytosine, United States Pharmacopeia (USP) Reference Standard
Flucytosine(Ancobon)
Flucytosine|||6-Amino-5-fluoropyrimidin-2(1H)-one
Flucytosinum
Flucytosinum [INN-Latin]
Flucytosone
Fluocytosine
Fluorcytosine
FT-0601273
GL663142 & 4-Amino-5-fluoropyrimidin-2(1H)-one
GL663142 & 5FC
GS-5578
HE000507
HE249467
HE323577
HMS1570L10
HMS2051M04
HMS2093J05
HMS2097L10
HMS2233I14
HMS3373L05
HMS3393M04
HMS3655G17
HSDB 3082
HY-B0139
I07-0006
KB-189054
KS-00000A18
KS-1060
LS-59140
LS40595
LT00771985
MCULE-7094058995
MFCD00006035
MFCD00179326
MFCD03547958
MLS000069463
MLS000759519
MLS001076503
MLS001424013
MolPort-000-155-561
MolPort-001-774-493
MolPort-002-317-353
NC00087
NCGC00016599-01
NCGC00016599-02
NCGC00016599-04
NCGC00016599-05
NCI60_000093
NSC 103805
NSC-103805
NSC-759130
NSC103805
NSC759130
Opera_ID_178
Pharmakon1600-01505429
Prestwick0_000934
Prestwick1_000934
Prestwick2_000934
Prestwick3_000934
QCR-271
Ro 2-9915
Ro 29915 E/265601
Ro-2-9915
Ro-29915
s1666
SAM001246753
SBB000061
SC-09037
SCHEMBL14696800
SCHEMBL24063
SMR000059047
SPBio_003037
ST028644
STK292386
TL8001667
Tox21_110515
Tox21_110515_1
UNII-D83282DT06
WLN: T6MVNJ DZ EF
XRECTZIEBJDKEO-UHFFFAOYSA-N
ZB015095
ZINC896546
ZLC0185
zlchem 343

US Patents and Regulatory Information for ANCOBON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant ANCOBON flucytosine CAPSULE;ORAL 017001-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant ANCOBON flucytosine CAPSULE;ORAL 017001-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Cantor Fitzgerald
Healthtrust
Teva
Chubb
UBS
QuintilesIMS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.